Article
[Determination of the lamivudine-resistant mutants of hepatitis B virus].
Orvosi hetilap - 22 Jun 2003
Gervain Judit, Papp Istvánné, Csöndes Mihály, Nemesánszky Elemér, Rácz István, Ribiczey Pál, Telegdy László, Tornai István, Weisz György
Abstract excerpt
INTRODUCTION: In addition to interferon, lamivudine is the other widely used antiviral agent in the therapy of chronic hepatitis B. This nucleoside analogue inhibits the RNA-dependent DNA polimerase and the reverse transcription by integrating in the viral DNA, which results in the secondary suppression of viral protein synthesis and replication of HBV. It has numerous advantages such as effective viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
